As of Thursday close, Abbott Laboratories’s (NYSE:ABT) stock was down -$1.51, moving down -1.45 percent to $102.90. The average number of shares traded per day over the past five days has been 4,226,480 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.85 fall in that time frame. In the last twenty days, the average volume was 4,144,410, while in the previous 50 days, it was 4,549,182.
Since last month, ABT stock retreated -5.27%. Shares of the company fell to $101.89 on 08/28/23, the lowest level in the past month. A 52-week high of $115.83 was reached on 07/24/23 after having rallying from a 52-week low of $93.25. Since the beginning of this year, ABT’s stock price has dropped by -6.28% or -$6.89, and marked a new high 7 times. However, the stock has declined by -11.16% since its 52-week high.
ABT stock investors should be aware that Abbott Laboratories (ABT) stock had its last reported insider trading activity 24 days ago on Aug 08. Wainer Andrea F, the EXECUTIVE VICE PRESIDENT of the company, disposed of 10,400 shares for $105.03 on Aug 08. It resulted in a $1,092,297 divestment by the insider. STARKS DANIEL J sold 50,000 shares at an average price of $113.76 on Jul 27. The insider now owns 6,775,316 shares following the transaction. On May 02, Director STARKS DANIEL J sold 50,000 shares at $111.02 apiece. The transaction was valued at $5,551,193.
Valuation Metrics
Right now, Abbott Laboratories (ABT) has a P/E ratio of about 34.99. The stock’s beta is 0.67. Besides these, the trailing price-to-sales (P/S) ratio of 4.42, the price-to-book (PB) ratio of 4.82, and the price-to-cash flow ratio of 32.39 may also be considered.
The latest dividend of $0.51 per share was paid out, remained unchanged from last year’s $0.51. On Friday December 9 2022, a $0.04 dividend increase was announced.
Financial Health
In the three months ended June 29, Abbott Laboratories’s quick ratio stood at 1.20, while its current ratio was 1.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.39, and the total debt-to-equity ratio was 0.45. On the profitability front, the trailing twelve-month gross margin is 55.20% percent. In the year ended June 29, EBITDA margin amounted to 26.64%, whereas operating margins totaled 15.20%. Based on annual data, ABT earned $24.51 billion in gross profit and brought in $43.65 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 13.00%. Return on equity (ROE) for the past 12 months was 14.10%.
In Abbott Laboratories’s quarter-end financial report for June 29, it reported total debt of $14.56 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ABT’s revenue fell -12.82% to $9.75 billion during the quarter, while net income inched up to $9.98 billion. While analysts expected Abbott Laboratories to report $1.05 quarterly earnings, the actual figure was $1.08 per share, beating the consensus estimate by 2.90%. During the quarter, the company generated $2.34 billion in EBITDA. The liabilities of Abbott Laboratories were 35.95 billion at the end of its most recent quarter ended June 29, and its total debt was $16.99 billion. The value of shareholders’ equity is $1.74 billion.
Technical Picture
This quick technical analysis looks at Abbott Laboratories’s (ABT) price momentum. With a historical volatility rate of 15.65%, the RSI 9-day stood at 37.20% on 31 August.
With respect to its five-day moving average, the current Abbott Laboratories price is down by -0.82% percent or -$0.85. At present, ABT shares trade -4.31% below its 20-day simple moving average and -0.77% percent below its 100-day simple moving average. However, the stock is currently trading approximately -3.15% below its SMA50 and -1.14% below its SMA200.
Stochastic coefficient K was 40.16% and Stochastic coefficient D was 34.80%, while ATR was 1.72. Given the Stochastic reading of 23.41% for the 14-day period, the RSI (14) reading has been calculated as 38.91%. As of today, the MACD Oscillator reading stands at -0.28, while the 14-day reading stands at -0.58.
